Science & Technology Theaters
Friday, June 26
AI in Action: Transforming Echo in Real-Time with the ACUSON Origin Ultrasound System
1:00-2:00 PM ~ Theater 1
Artificial intelligence is redefining what is possible in echocardiography moving beyond isolated tools to become an integral part of the imaging workflow. This symposium highlights how AI, built directly into the ACUSON Origin, is helping enable more efficient, consistent, and reproducible cardiac ultrasound examinations.
Moderated by Lissa Sugeng, MD, MPH, FASE, this session will begin with an overview of how AI is being implemented within echocardiography, including key considerations for clinical integration and the evolving role of AI in supporting imaging professionals.
Steven Walling, BS, ACS, RCS, RDCS, FASE, will discuss AI and the evolving workforce, focusing on how AI-enabled automation embedded within the ACUSON Origin workflow can help simplify acquisition, support training and onboarding, and reduce the burden of repetitive tasks, contributing to a more sustainable imaging environment.
Robert Burke, MD, FASE, will highlight next-generation innovations on ACUSON Origin, including AI-driven valve quantification, fusion imaging aligning ultrasound and fluoroscopy, and advanced 3D rendering technologies used for visualization and procedural guidance.*
Ashlee Davis, BSMI, ACS, RDCS, RCCS, FASE, will provide a clinical user perspective, sharing how AI integrated into the ACUSON Origin supports daily practice streamlining workflow, improving usability, and enabling greater consistency across exams.
Together, these perspectives illustrate how integrated AI is shaping the future of echocardiography with the ACUSON Origin.
*510(k) pending, not yet commercially available in the United States
Optimizing Echocardiographic Assessment & Care Pathways with the American Heart Association’s Target: Aortic Stenosis
1:00-2:00 PM ~ Theater 2
This lecture reviews ASE guideline-recommended echocardiographic techniques for assessment of aortic stenosis, highlights sources of variability in severity assessment and mitigation strategies and shows how Target: Aortic Stenosis promotes best practices to improve diagnostic consistency and patient outcomes.
Sreekanth Vemulapalli, MD (Chair)
Target: Aortic Stenosis SAG Member, Medical Director of Duke Echo Lab and Cardiac Diagnostics Unit
Associate Professor, Duke University
Alicia Armour, MA, RDCS, FASE
Health Center Administrator at Duke Triangle Heart Associates,
Duke Heart Center
Jordan Strom, MD, MSc, FASE
Director, Echocardiography Lab at Beth Israel Deaconess Medical
Center
Associate Professor, Harvard Medical School
Marielle Scherrer-Crosbie, MD, PhD, FASE
Target: Aortic Stenosis SAG Member, Director, Cardiac Ultrasound Laboratory Professor of Medicine, Hospital of the University of Pennsylvania
Saturday, June 27
Unlocking New Possibilities in Echo Artificial Intelligence, Adaptive Imaging and Color Flow, Ergonomic Design, LAA Assessment, and Real-Time 4D ICE in Clinical Practice
12:30-1:30 PM ~ Theater 2
Join expert faculty to explore how these innovations enhance imaging, improve efficiency, and support more confident clinical decisions.
Decisive Imaging: UEA Accuracy Can Aid Confident Clinical Management
3:45-4:30 PM ~ Theater 1
Learn how ultrasound enhancing agents (UEA) can enhance image clarity and precision diagnosing hypertrophic cardiomyopathy, heart failure and apical thrombi. UEA may support measurement accuracy for chemotherapy cardiotoxicity, valve interventions and ICD/CRT devices, enabling clinical management.
Lissa Sugeng, MD, MPH
Implementing Echocardiography Guidelines for Hypertrophic Cardiomyopathy
3:45-4:30 PM ~ Theater 2
This program provides an overview of the HCM mechanism of disease and detailed guidance for usingechocardiography for diagnosis and HCM disease management, including patient case examples with realpatient echocardiography imagery.
James P MacNamara, MD, MSCS, FASE
Assistant Professor
Associated Director of Echocardiography Laboratory
Division of Cardiovascular Medicine
University of Virginia Health
Sunday, June 28
Echocardiographic Insights for Sonographers: Considerations for Patients WithObstructive Hypertrophic Cardiomyopathy (oHCM)
12:30-1:30 PM ~ Theater 1
Join us for an engaging session designed specifically for sonographers,
offering practical insights into the role of echocardiography in monitoring and evaluating patients with HCM.
Ashlee Davis, ACS, RDCS, RCCS, BSMI, FASE
Chief Technologist
Duke University Hospital
Durham, NC
